Microfluidic Sperm Selection Before ICSI in Bengaluru: What Should Patients Ask?

Microfluidic sperm-selection devices separate sperm using channels and flow properties. They are laboratory-processing options, not treatments for every cause of male infertility, and a favourable laboratory measurement is not itself evidence of a higher live-birth chance. For patients in Jayanagar, Bengaluru, the practical goal is to resolve the question using the existing medical record before committing to additional tests or procedures. A locality reference is for search relevance and patient planning; it is not a claim that HomeIVF operates a clinic there.

Conventional sperm preparation may use density gradients or swim-up methods, while microfluidic systems use small channels to help separate a motile fraction. Which approach is appropriate depends on the sample and the laboratory’s validated process. A marketing phrase such as “DNA-safe sperm” oversimplifies what the device measures. Ask what parameter is expected to improve, what the device cannot assess and how the sperm will be used in the planned ICSI procedure.

When a clinician recommends microfluidic selection because of an elevated DNA-fragmentation result, distinguish association from proof of benefit. Semen DNA-fragmentation assays, specimen handling and thresholds vary; NICE’s 2026 infertility guideline does not recommend routine sperm DNA-integrity testing. A new device does not repair DNA already damaged. Discuss whether another clinical cause or an actionable male-factor finding should be addressed instead.

Assess the whole couple. An age-related egg concern, tubal disease or uterine problem cannot be solved by choosing a sperm-preparation gadget. Equally, one disappointing fertilisation cycle deserves an embryology review rather than reflexively buying every laboratory add-on. Collect the original semen report, medical history, previous fertilisation notes, any medications and a clearly documented reason the laboratory expects microfluidics to change the result.

Before booking an additional appointment, write down one question the test, procedure or consultation is intended to answer. Ask whether an existing report already answers it, whether timing or measurement makes that report unreliable and what the team would do with either a positive or negative result. A review that cannot change a decision may not justify another test.

Before signing consent, ask how many usable sperm the method may yield from the available specimen, whether a backup selection technique exists, and what happens if the device produces too few cells. The laboratory should explain the operational limitations, not just display before-and-after pictures. Ask whether the processed sample remains available for standard verification and whether the result would ever lead the team to change the planned treatment.

An extra laboratory method or medicine should have its own purpose and informed-consent discussion. Ask whether the option is part of the centre’s ordinary validated pathway, a separately priced selection method, or a treatment being offered despite uncertain evidence. A change in embryo appearance, a laboratory score or a physiological marker does not automatically prove more live births. The comparator matters: what would happen using the standard approach without the add-on?

Compare the fee with the whole ICSI pathway and ask if it is charged regardless of outcome. If a couple requests this option only because a social media video described it as “advanced,” an evidence check is especially valuable. Informed choice means knowing the uncertain benefits, the exact cost, and the alternative with similar baseline care; no patient should be pressured into an add-on through fear.

Ask for the standard-cycle quotation and a second version showing the additional technique separately. The estimate should state the stage at which the fee becomes payable, what happens if the procedure cannot be used, and whether the cost applies again in a later cycle. Record the medical rationale, expected benefit, plausible risk and level of evidence, rather than accepting an unqualified claim that modern technology guarantees better outcomes.

For someone balancing treatment with work or family responsibilities, fewer unnecessary journeys can matter. HomeIVF may enable doctor-led review of reports, certain consultations, selected authorised home blood collection, medication support and care coordination, subject to clinical judgment and verified availability. Make a simple list of tasks that can be remote and those needing the facility; never assume an appointment is optional because it is inconvenient.

Ultrasound examinations, when required, need suitable imaging equipment and trained professionals. Egg retrieval, sperm preparation where relevant, fertilisation, embryo culture, cryostorage and embryo transfer require appropriate specialist facilities. Serious symptoms need in-person assessment, often urgently. No infographic or patient article should imply that eggs can be retrieved, embryos created or transfers performed in someone’s bedroom.

A Jayanagar couple can review records with the doctor without repeated clinic trips. Any actual sperm preparation, injection and culture must occur in a trained reproductive laboratory. Neither home blood collection nor home injection support makes microfluidic sperm selection a home procedure. Whether a specific Bengaluru lab has a validated device remains a local facility claim to verify. Seek urgent care for relevant warning signs: Severe testicular pain, fever or acute scrotal swelling merits prompt in-person assessment.

Before booking the next procedure, send the treating clinician the question you want answered and the reports that might answer it. Ask for a one-page plan covering what is known, what needs checking, which visits are essential, who gives instructions for medicines and whom to contact if symptoms change. Request the total cost in writing and a separate explanation of optional items. This preserves decision quality while avoiding unnecessary journeys. Before using a new sperm-processing add-on, check whether the actual sample characteristics are compatible with the technology. A device that needs motile sperm may not provide meaningful output from every highly abnormal specimen. The laboratory should have a documented fallback if the selected sample is inadequate.